Arbovirus Infection
A special issue of Epidemiologia (ISSN 2673-3986).
Deadline for manuscript submissions: closed (31 August 2021) | Viewed by 3451
Special Issue Editor
2. Center for Vaccines and Therapeutic Antibodies for Emerging Infectious Diseases, Shimane University, Izumo 690-8504, Japan
Interests: dengue virus; zika virus; chikungunya virus; serology; molecular epidemiology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Arboviruses—arthropod-borne viruses—are globally emerging and reemerging pathogens that are important causes of human disease throughout the world. Arboviruses are transmitted biologically among vertebrate by hematophagous arthropods, including mosquitoes, ticks, sandflies, and biting midges. Arboviruses include a wide variety of RNA viruses, and members of the Flavivirus and Togavirus genera are the most important arboviruses that cause diseases in humans. Examples include four dengue viruses (DENV), Japanese encephalitis virus (JEV), West Nile virus (WNV), Zika virus (ZIKV), Yellow Fever virus (YFV), tick-borne encephalitis virus (TBEV), and Chikungunya virus (CHIKV).With the recent outbreak of DENV, YFV, ZIKV, and CHIKV infections, the interest in arbovirus has increased. To develop vaccines and specific therapeutic treatments, it is necessary to determine the viral and host factors enhancing arbovirus infection.
In this Special Issue, we aim to assemble a collection of research papers and reviews that consider serological aspects, molecular features of arboviruses, virus–host interactions, and viral pathogenesis in animal models to promote the discovery of antiviral drugs and vaccine development. We look forward to your submissions.
Dr. Mya Myat Ngwe Tun
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Epidemiologia is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
